Authors/Disclosures
|
Aga J. Lewelt
|
No disclosure on file |
|
Omar A. Danoun, MD
(Henry Ford Hospital)
|
Dr. Danoun has nothing to disclose. |
|
Adam Witt, MD
(University of Alberta Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
John T. Kissel, MD, FAAN
|
Dr. Kissel has nothing to disclose. |
|
Thomas O. Crawford, MD
(Johns Hopkins Hospital)
|
Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. |
|
Gyula Acsadi, MD, FAAN
(Connecticut Children'S Medical Center/UConn)
|
Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. |
|
|
No disclosure on file |
|
Bakri Elsheikh, MD, FAAN
(The Ohio State University Wexner Medical Center)
|
Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA. |
|
Sandra P. Reyna, MD
|
Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies. |
|
|
No disclosure on file |
|
Mary K. Schroth, MD
(Cure SMA)
|
Dr. Schroth has received personal compensation for serving as an employee of Cure SMA. The institution of Dr. Schroth has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schroth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Schroth has received research support from Biogen. |
|
Louise R. Simard, PhD
(University of Manitoba)
|
No disclosure on file |
|
|
No disclosure on file |
|
Kathryn J. Swoboda, MD
|
Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen. |